Showing results (71-80 of 389) with videos related to
Sort By:
Pageof 39
Urology|September 4, 1999
Plasma levels of vascular endothelial growth factor are increased in patients with metastatic prostate cancerJ L Duque, K R Loughlin, R M Adam, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2001
Prognostic significance of reverse transcriptase polymerase chain reaction for prostate-specific antigen in men with hormone-refractory prostate cancerP W Kantoff, S Halabi, D A Farmer, et al.Cancer|June 20, 2001
Low bone mineral density in hormone-naïve men with prostate carcinomaM R Smith, F J McGovern, M A Fallon, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 29, 1998
Debrisoquine hydroxylase (CYP2D6) and prostate cancerP G Febbo, P W Kantoff, E Giovannucci, et al.Cancer|October 24, 2000
Vinorelbine and estramustine in androgen-independent metastatic prostate cancer: a phase II studyM R Smith, D Kaufman, W Oh, et al.Prostate Cancer and Prostatic Diseases|June 25, 2014
Time to disease-related pain and first opioid use in patients with metastatic castration-resistant prostate cancer treated with sipuleucel-TE J Small, C S Higano, P W Kantoff, et al.Current Opinion in Molecular Therapeutics|November 9, 2001
Recent advances in retrovirus vector-mediated gene therapy: teaching an old vector new tricksE Weber, W F Anderson, N KasaharaJournal of Virology|September 1, 1997
Functional interactions between monomers of the retroviral envelope protein complexY Zhao, S Lee, W F AndersonJournal of Virology|October 1, 1995
Binding kinetics of ecotropic (Moloney) murine leukemia retrovirus with NIH 3T3 cellsH Yu, N Soong, W F AndersonPageof 39